|
|
Volumn 36, Issue 8, 2004, Pages 2384-2385
|
|
Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
LIPID;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
BIOCHEMISTRY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GLUCOSE INTOLERANCE;
GRAFT REJECTION;
HEART MUSCLE BIOPSY;
HEART TRANSPLANTATION;
HEMATOLOGY;
HEMODYNAMICS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MALE;
MICROEMULSION;
NEPHROTOXICITY;
NEUROTOXICITY;
PRIORITY JOURNAL;
RABBIT;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
RECIPIENT;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
SURVIVAL RATE;
TIME SERIES ANALYSIS;
ADULT;
CYCLOSPORINE;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIPIDS;
MALE;
MIDDLE AGED;
PROBABILITY;
TACROLIMUS;
|
|
EID: 9244231773
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.059 Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (6)
|
